Derivation and external validation of dendritic cell-related gene signatures for predicting prognosis and immunotherapy efficacy in bladder urothelial carcinoma

Immunogenic Cell Death Role in Urothelial Cancer Therapy

Immune escape mechanisms and immunotherapy of urothelial bladder cancer

Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities

Persistent Newcastle disease virus infection in bladder cancer cells is associated with putative pro-survival and anti-viral transcriptomic changes

Novel immunotherapy combinations for genitourinary cancers

Preliminary results of a phase I clinical trial using an autologous dendritic cell cancer vaccine targeting HER2 in patients with metastatic cancer or operated high-risk bladder cancer (NCT01730118).

Vaccination of Urological Cancer Patients With WT1 Peptide-Pulsed Dendritic Cells in Combination With Molecular Targeted Therapy or Conventional Chemotherapy Induces Immunological and Clinical Responses

Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature